Research also showed that those taking tirzepatide were more likely to achieve 5% or greater, 10% or greater, and 15% or greater weight loss, and lost more weight over 3, 6, and 12 months
Weight loss helps to decrease the risk of obesity related consequences such as diabetes, high blood pressure, and heart disease
Low ineffective doses may deliver no benefit while still costing money
The blend is supplied co-lyophilised, meaning both peptides are dissolved together when the vial is reconstituted
academic medical clinics, finding that most patients had kept the weight off or lost even more weight 18 months after stopping semaglutide, sold as Ozempic and Wegovy, or tirzepatide, sold as Mounjaro and Zepbound